Literature DB >> 2787183

Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis.

M Soden1, M Rooney, A Cullen, A Whelan, C Feighery, B Bresnihan.   

Abstract

The spectrum of immunohistological change in the affected joints of patients with rheumatoid arthritis has been well described. In this study, the immunohistological features in synovial membrane obtained from apparently uninvolved knee joints of 16 patients with active untreated rheumatoid arthritis were examined and compared to tissue from control subjects. Synovial tissue was obtained by needle biopsy. Hyperplasia of the synovial lining layer, present in 69%, was the most frequently observed abnormality in synovium obtained from uninvolved joints. Perivascular mononuclear cell infiltration was present in 31% and consisted predominantly of helper T-cells. Increased vascularity and fibrin deposition were not notable features. Clinically overt synovitis emerged in only two patients during a follow-up period of up to 36 months. In conclusion, a considerable degree of histological change was observed in the apparently uninvolved knee joints of patients with active rheumatoid arthritis. The presence of subclinical synovitis challenges current concepts of disease activity and clinical remission. Further study is required to determine whether the features described may be associated with progressive joint erosion.

Entities:  

Mesh:

Year:  1989        PMID: 2787183     DOI: 10.1093/rheumatology/28.4.287

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  24 in total

Review 1.  Synovial biopsy in arthritis research: five years of concerted European collaboration.

Authors:  B Bresnihan; P P Tak; P Emery; L Klareskog; F Breedveld
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

2.  Immunohistochemistry of normal human knee synovium: a quantitative study.

Authors:  J A Singh; T Arayssi; P Duray; H R Schumacher
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

3.  Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease.

Authors:  R J Wakefield; M J Green; H Marzo-Ortega; P G Conaghan; W W Gibbon; D McGonagle; S Proudman; P Emery
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

4.  Sonography and subclinical synovitis.

Authors:  B Bresnihan; D Kane
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

5.  Correlations between both the expression levels of inflammatory mediators and growth factor in medial perimeniscal synovial tissue and the severity of medial knee osteoarthritis.

Authors:  Liang Ning; Muneaki Ishijima; Haruka Kaneko; Hidetake Kurihara; Eri Arikawa-Hirasawa; Mitsuaki Kubota; Lizu Liu; Zhuo Xu; Ippei Futami; Anwarjan Yusup; Katsumi Miyahara; Shouyu Xu; Kazuo Kaneko; Hisashi Kurosawa
Journal:  Int Orthop       Date:  2010-06-02       Impact factor: 3.075

6.  Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis.

Authors:  O FitzGerald; M Soden; G Yanni; R Robinson; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 7.  Utility of arthroscopic guided synovial biopsy in understanding synovial tissue pathology in health and disease states.

Authors:  Mihir D Wechalekar; Malcolm D Smith
Journal:  World J Orthop       Date:  2014-11-18

Review 8.  Synovial tissue research: a state-of-the-art review.

Authors:  Carl Orr; Elsa Vieira-Sousa; David L Boyle; Maya H Buch; Christopher D Buckley; Juan D Cañete; Anca I Catrina; Ernest H S Choy; Paul Emery; Ursula Fearon; Andrew Filer; Danielle Gerlag; Frances Humby; John D Isaacs; Søren A Just; Bernard R Lauwerys; Benoit Le Goff; Antonio Manzo; Trudy McGarry; Iain B McInnes; Aurélie Najm; Constantino Pitzalis; Arthur Pratt; Malcolm Smith; Paul P Tak; Rogier Thurlings; João E Fonseca; Douglas J Veale; Sander W Tas
Journal:  Nat Rev Rheumatol       Date:  2017-07-13       Impact factor: 20.543

9.  Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.

Authors:  A Crilly; R Madhok; J Watson; H A Capell
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

10.  Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium.

Authors:  O S Jamal; P G Conaghan; A M Cunningham; P M Brooks; V F Munro; K F Scott
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.